crispr-cas9 grna (Integrated DNA Technologies)
Integrated DNA Technologies is a verified supplier 
Integrated DNA Technologies manufactures this product 
95
Structured Review
Integrated DNA Technologies
crispr-cas9 grna
Crispr Cas9 Grna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 95/100, based on 233 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr-cas9+grna/CRISPR-Cas9+gRNA/custom%40crispr-cas9-grna%4042667516
Average 95 stars, based on 233 article reviews
Crispr Cas9 Grna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 95/100, based on 233 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr-cas9+grna/CRISPR-Cas9+gRNA/custom%40crispr-cas9-grna%4042667516
Average 95 stars, based on 233 article reviews
crispr-cas9 grna - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Activity Assay:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Recombinant:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Control:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Clone Assay:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Sequencing:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Mutagenesis:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Isolation:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Transfection:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, CRISPR:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, Cell Culture:Article Title: CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients Article Snippet: 3 ), was selected for further evaluation in PBMCs from the same donor (NIC0071). Synthetic guide RNAs were complexed with recombinant SpCas9 by adding 2.2 μl of Alt-R™ S.p. Cas9 Nuclease V3 (10 mg/ml, |